Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Summary of treatment‐emergent adverse events (all‐causality; mITT population)
| n (%) | PF‐05280586 | Rituximab‐EU | Rituximab‐US |
|---|---|---|---|
| n = 73 | n = 74 | n = 73 | |
| Patients with AEs | 50 (68.5) | 41 (55.4) | 45 (61.6) |
| Patients with treatment‐related AEs | 22 (30.1) | 17 (23.0) | 18 (24.7) |
| Patients with serious AEs | 5 (6.8) | 1 (1.4) | 4 (5.5) |
| Patients withdrawn from treatment owing to AEs | 2 (2.7) | 1 (1.4) | 1 (1.4) |
| Patients with AEs grade ≥3 | 10 (13.7) | 1 (1.4) | 10 (13.7) |
AE, adverse event; mITT, modified intent‐to‐treat.
